Euroopa Liit - eesti - EMA (European Medicines Agency)

sandoz gmbh - natalisumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Euroopa Liit - eesti - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukeemia, müeloid - antineoplastilised ained - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukeemia, müeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Eesti - eesti - Ravimiamet

zentiva k.s. - oksükodoon - toimeainet prolongeeritult vabastav tablett - 20mg 60tk; 20mg 10tk; 20mg 30tk; 20mg 90tk; 20mg 56tk

Eesti - eesti - Ravimiamet

zentiva k.s. - oksükodoon - toimeainet prolongeeritult vabastav tablett - 40mg 30tk

Eesti - eesti - Ravimiamet

zentiva k.s. - oksükodoon - toimeainet prolongeeritult vabastav tablett - 10mg 30tk; 10mg 98tk; 10mg 10tk; 10mg 20tk; 10mg 60tk; 10mg 120tk; 10mg 90tk; 10mg 28tk; 10mg 56tk; 10mg 112tk

Eesti - eesti - Ravimiamet

reckitt benckiser (poland) s.a. - flurbiprofeen - suuõõnesprei, lahus - 8,75mg 1annus 15ml 1tk

Eesti - eesti - Ravimiamet

wick pharma zweigniederlassung der procter & gamble gmbh - paratsetamool+pseudoefedriin+difenhüdramiin - õhukese polümeerikattega tablett - 500mg+60mg+0/500mg+0+25mg 12tk / 4tk

Eesti - eesti - Ravimiamet

intervet international b.v. - amoksitsilliin - suukaudse lahuse pulber - 697mg 1g 100g 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - salbutamool - inhalatsiooniaerosool, suspensioon - 100mcg 1annus 200annus 2tk